Analyzing cancer through advanced genomic techniques
Immunogenomics platform for the analysis of cancer
This study is looking at how changes in genes can influence how well immunotherapy works for cancer patients, like those with melanoma or lung cancer, to help create more personalized treatment plans that could lead to better results.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10977134 on NIH RePORTER |
What this research studies
This research focuses on using advanced computational methods to analyze genetic data from cancer patients, particularly through Next Generation Sequencing (NGS). The goal is to enhance our understanding of how genetic alterations affect the efficacy of immunotherapy treatments in various cancers, including melanoma and lung cancer. By leveraging large datasets, the research aims to identify molecular drivers that can inform personalized treatment strategies for patients. The findings could lead to improved outcomes for individuals undergoing immunotherapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients, particularly those with melanoma or non-small cell lung cancer, who are considering or currently receiving immunotherapy.
Not a fit: Patients with early-stage cancers or those not receiving immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized immunotherapy treatments for cancer patients.
How similar studies have performed: Previous research has shown success in using computational genomics to improve immunotherapy outcomes, indicating that this approach has the potential for significant advancements.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Makarov, Vladimir — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Makarov, Vladimir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.